Genvor (OTCQB:GNVR) CEO to Present Corporate Update at NIBA Conference

WOODLAND, CA — March 5, 2026 — Leads & Copy — Genvor, Inc. CEO Chad Pawlak will present at the National Investment Banking Association’s (NIBA) 152nd Investment Conference in Fort Lauderdale, Florida, on March 12, 2026.

The presentation will provide a corporate update, highlighting recent milestones, technology platform advancements, and upcoming growth initiatives. Attendees and investors are encouraged to schedule one-on-one meetings with management during the conference.

The NIBA conference will be held March 11-12, 2026, at the Westin Fort Lauderdale Beach Resort. Registration information is available on the NIBA conference website.

Genvor, Inc. is a biotechnology company utilizing AI to generate peptides for agriculture and human health. The company’s BioCypher platform designs peptides to enhance crop performance, reduce chemical inputs, and support human recovery and wellness. Genvor uses strategic partnerships and a dual-market commercialization model to advance peptide science.

The National Investment Banking Association (NIBA) is a non-profit organization serving the micro-cap and small-cap investment community for over 40 years.

Source: Genvor, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.